ESMO shared on X:
“ESMOGI24: Updated results from the TRANSMET trial showed that chemotherapy combined with liver transplantation in highly selected patients with CRC quadrupled the 5-year OS rate VS chemotherapy alone.
Link to ESMO Daily Reporter.”
Source: ESMO/X